WASF3 and breast cancer: Together, the data derived from the immunohistochemistry analysis of WAVE3 expression levels in 128 breast cancer specimens and its correlation with the tumor-associated clinical and pathological parameters as well the disease and survival outcomes, clearly demonstrated a significant association between WAVE3 expression levels and BC progression and metastasis.